- Excellence in Oncology
- QiC Connect
- Therapy Areas
Supporting the NHS Outcomes Framework 2013/14, and based upon the successful Pfizer Excellence in Oncology Awards, the second QiC Excellence in Oncology programme was launched at this year’s Healthcare Innovation Expo conference in London.
The programme recognises, rewards and shares good oncology healthcare practice, and is supported by partners in industry, NHS and charities. This diverse partnership will help to increase the outreach of the programme and share good practice with a wider audience.
Each entry will be reviewed by a multidisciplinary panel of eminent oncology professionals, and representatives from cancer patient groups, and industry.
There are nine different categories specifically aimed at professionals from diverse fields within oncology (clinical practice, research and the not-for-profit/charitable sector). All categories support one or more of the domains as defined by the NHS Outcomes Framework 2013/14 to help the health and care system to focus on measuring outcomes.
The initiatives must be well thought-out, have a demonstrable impact on clinical practice, show innovation and contribute to the optimisation of service delivery, ultimately benefiting people with cancer. Judges will favour projects that demonstrate results that have quality and/or efficiency benefits which are scalable, thereby having a greater impact than their initial focus.
Embrace this opportunity to be recognised and rewarded for good practice initiatives and hard work, as well as the opportunity to share your work with eminent oncology professionals and representatives from oncology patient groups and industry.
We are passionate about using QiC Excellence in Oncology to recognise the past and shape the future – but we need your help to do it!
Entry closing date: 18:00hrs, Friday June 28, 2013
A Cheshire man was last week presented with a national award for his honest, open...continue reading;i>
Cambridge University Hospitals (CUH) decided to implement ThinkGlucose in November 2009, having identified that 16 per cent of its in-patients had diabetes.
After establishing its... continue reading